Selective Estrogen Receptor Degraders (SERDs) are a class of drugs that target the estrogen receptor and reduce its activity. They are used to treat hormone-dependent breast cancer and other estrogen-related conditions. SERDs work by blocking the binding of estrogen to its receptor, thus reducing the amount of estrogen that can activate the receptor. This can help reduce the growth of cancer cells that rely on estrogen for growth and survival.